SynergiQc, our biopharmaceutical R&D funding program, is designed to support innovation in …
EncephalX, a Canadian medtech company, has closed a CAD $2.25M oversubscribed pre-seed round to…
adMare BioInnovations is proud to announce the creation of Ocythera, a new biopharmaceutical company dedicated to…
BIOQuébec submitted its pre-budget briefing paper, “For a competitive and innovative Québec in…
The investment will expand RNA Technologies & Therapeutics’ operations and …
The Faculty of Pharmacy at the University of Montreal and Millénium Quebecor recently launched recruitment for…
Helping Health Technology Companies Navigate International Growth…
We use cookies to improve your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Privacy Policy